Healthcare Sector — Q4 FY26 Earnings Overview

API prices remain lower than last year despite recent uptick; further decline could delay turnaround and keep losses elevated.

The FY27 revenue target of 260 crore and 500+ bed capacity by 2028 appear aggressive given current run-rate and regulatory hurdles.

Geopolitical tensions have increased freight costs and transit times; if prolonged, could impact Asia business recovery and margins.

Two large commercial molecules under destocking may not return as expected; management declined to quantify value, creating uncertainty.

Historical reliance on a few molecules led to revenue volatility; diversification is improving but still a risk.